INTRODUCTION
Clofibrate (ethyl-a-p-chlorophenoxyisobutyrate), the most \Videly used hypolipidemic drug in the U.S. and Europe [1] has been shown to induce hyperplastic and neoplastic changes in rat liver (2, 3] . Epidemiologie investigations in man have revealed an increased incidence of various malignant neoplasms but the findings are not statistically significant [4) . Fenofibrate (isopropyl-{4' (p .. chloro" benzoyl)-2·phenoxy-2-methyl)-propionate; procetofene; Lipanthyf!l ; LF 178), structurally related to clofibrate, is about 6 times more active as a hypolipidemic agent [5) . No reports on long-term carcinogenicity studies with fenofibrate have been published.
These two and other hypolipidemic drugs cause a marked increase of liver peroxisomes in rodents accompanied by a marked hepatomegaly [6] [7] [8] , and it was postulated in a recent report [9] For the high-dose experiment, they were diluted with inactive material (Laboratoires Fournier S.A., Dijon, France) to specific activities of 2.63 mCi/mmol and 2.82 mCi/mmol for the clofibric and fenofibric acid, respectively. The compounds were administered p.o. in 0.5 ml dimethyl sulfoxide to Sprague-Dawley-derived SIV 50 rats weighing about 200 g. They were fed with Nafag laboratory chow No 890 (Nafag AG, Gossau, Switzerland) and were given tap water ad lib. 10 h after the administration, the rats were killed by open-heart puncture under ether anesthesia, the livers were excised, and a nuclear fraction was prepared according to Viviani et al. [13] . Nuclear protein was precipitated 4 times with acetone and purified by dialysis and one more acetone precipitation step [14] . DNA was isolated by the 307 method of Markov and lvanov [15] with some modifications [14] . The highly purified DNA (less than 0.1 o/o protein) was dissolved in 4 ml 0.014 M phosphate buffer (pH 6.8) and the scintillation counting was performed after addition of 10 ml InstaGel (Packard Instruments, Downers Grove, IL, USA). The amount of DNA was determined by assuming an absorbance of 20 at 260 nrn for a solution of 1 mg DNA/ml. The protein was dissolved in 4 ml 1 OJo sodium dodecyl sulfate and counted by adding 1 ml to 10 ml Insta-GeL The amount of protein was measured by the method of Lowry et al. [16] .
RESULTS AND DISCUSSION
Compounds I and II, both 14 C-labelled in the indicated position, were administered in low and high dose Ievels by gastric intubation to young adult rats. Nuclear DNA and protein were isolated from the livers after I 0 h and the radioactivity of the macromolecules was determined. Whereas on the protein a radioactivity in the order of 9 to 78 dpm/mg could be detected, the corresponding DNA values were just above the Iimit of detection (clofibric acid, high dose) or not measurable at all (all other cases) ( Table I) .
Two dose levels were used in our binding experiments to detect possible saturation of metabolic pathways which might Iead to qualitative changes in the pattern of metabolites.
The minute radioactivity detected on the DNA after clofibrate administration most probably does not indicate covalent binding of the drug to DNA but is due to biosynthetic incorporation of radioactivity. After oral administration of clofibric acid Iabelied at the terminal carboxyl group, 0.850Jo of the dose (high-dose experiment) was exhaled within 10 h as 14 C02. C02 is one of the precursors for the purine biosynthesis so that the radioactivity detected on the DNA might weH have been incorporated. A control experiment was therefore performed: After oral administration of 15 mg/kg 14 CH30H to rats, 80o/o of the radioactivity was exhaled as 14 C02. The radioactivity which was incorporated into liver DNA, 12 h after this administration, corresponded to an apparent CBI of 170. These results were compatible with the above-mentioned hypothesis. With fenofibric acid, the Iabel is not in the terminal carboxyl group and a release of radioactivity into the pool of nucleic acid precursors is much less likely. This is in agreement with the much smaller fraction of 0.06o/o of the radioactive dose that is exhaled as 14 C0 2 • In order to compare chemieals of varying DNA-binding abilities, the binding potency is expressed as a CBI = DNA damage/ dose [17] . The strongest hepatocarcinogenic compounds with a genotoxic, initiating mode of action, e.g. aflatoxin Bt or dimethylnitrosamine, exhibit a CBI in the order of 10 3 to 104. Moderate hepatocarcinogens like 2-acetylaminofluorene and vinyl chloride show a CBI of about 1 ()2. As estimated from the long-term carcinogenicity data with clofibrate [3] , and by using a linear relationship between carcinogenicity and CBI [ 18] , a CBI of 10 . Protein binding tends to Iead to cytotoxicity and it is conceivable that the regenerating processes elicited from a high dose of a cytotoxic drug might have a promoting effect on any pre-existing pre-cancerous lesion set by ubiquitous genotoxic agents.
The present data exclude somatic mutations as a carcinogenic mode of action of these two drugs. A risk assessment for man must therefore be based upon their cancer-promotive activities. Many other frequently -used compounds such as phenobarbital or halogenated pesticides show a similar mode of action. Threshold Ievels, non-linear dose-tumor relationships and a strong correlation with cell metabolism are more likely to be found with promoting activities than with initiating, genotoxic compounds. An extrapolation of any 'carcinogenicity data from rats to man must therefore await a comparison over a wide dose range of a number of biochemical effects of these drugs, viz., induction of microsomal enzymes, hypertrophy and hyperplasia of the Ii ver.
